|
Market Closed -
Japan Exchange
12:00:00 10/04/2026 pm IST
|
5-day change
|
1st Jan Change
|
|
2,772.50 JPY
|
-1.21%
|
 |
-3.18%
|
-17.19%
|
|
02/04 |
Adlai Nortye Ltd. Announces President Changes, Effective April 1, 2026
|
CI
| |
26/02 |
Daiichi Sankyo Company, Limited Announces Board Retirements, Effective March 31, 2026
|
CI
| |
26/02 |
Daiichi Sankyo Company, Limited Announces Retirement of Sunao Manabe as Representative Director Executive Chairperson, Effective February 26, 2026
|
CI
| |
24/02 |
Daiichi Sankyo Company, Limited Announces Executive Changes Effective from April 1, 2026
|
CI
| |
20/02 |
Daiichi Sankyo Company, Limited Announces Executive Changes, Effective April 1, 2026
|
CI
| |
22/01 |
Daiichi Sankyo Appoints Veronika Rozehnal, Ph.D., as Head of Translational Research Center Europe
|
CI
| |
04/25/04 |
BP Chair to step down; AstraZeneca touts EU approval
|
AN
| |
20/25/20 |
Immuneering Names Dr. Igor Matushansky, MD, PhD, as Chief Medical Officer
|
CI
| |
03/25/03 |
Daiichi Sankyo Names CEO
|
MT
| |
31/25/31 |
Daiichi Sankyo Company, Limited Announces Chief Executive Officer Changes, Effective April 1, 2025
|
CI
| |
16/24/16 |
Daiichi Sankyo Company, Limited Announces Executive Changes
|
CI
| |
11/24/11 |
Daiichi Sankyo: Will Boost ADC Cancer Drug Production
|
MT
| |
10/24/10 |
Pascal Soriot, CEO of AstraZeneca : New lung cancer treatment shows two-month improvement in survival
|
MT
| |
07/23/07 |
INTERVIEW - Hiroyuki Okuzawa, CEO of Daiichi Sankyo: Confident about the future thanks to the drug pipeline
|
MT
| |
16/23/16 |
Daiichi Sankyo Company, Limited Announces Retirement of Noritaka Uji, Outside Director
|
CI
| |
01/23/01 |
Daiichi Sankyo Posts 8% Decline in Fiscal Nine-month Attributable Profit on Growing Expenses; Rejigs Management Structure
|
MT
| |
31/23/31 |
Daiichi Sankyo Company, Limited Appoints Hiroyuki Okuzawa as New President & COO Effective as of April 1, 2023
|
CI
| |
13/21/13 |
Daiichi Sankyo Company, Limited Announces Executives Retirement, Effective as of June 21, 2021
|
CI
| |
22/21/22 |
Daiichi Sankyo Appoints Ken Takeshita, MD as Global Head of R&D with Effect from April 1, 2021
|
CI
| |
22/21/22 |
Daiichi Sankyo Company, Limited Appoints New Corporate Officers, Effective April 1, 2021
|
CI
| |
11/20/11 |
Daiichi Sankyo Company, Limited Announce Board Resignations
|
CI
| |
10/19/10 |
Daiichi Sankyo Company, Limited Announces Changes to Members of the Board and Members of the Audit and Supervisory Board
|
CI
| |
25/19/25 |
Daiichi Sankyo Company, Limited Announces Management Changes
|
CI
| |
29/19/29 |
Daiichi Sankyo Company, Limited Announces the Management Changes
|
CI
| |
22/19/22 |
Daiichi Sankyo Company, Limited Announces Executive Changes
|
CI
|
No results for this search Select your edition All financial news and data tailored to specific country editions
MarketScreener is also available in this country: United States.
Switch edition
Stay in the current country edition
| 
